baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out PGR/ DE000ME8Z0C0 /

07/06/2024 21:47:31	Chg.-	Bid11:34:34	Ask11:34:34	Underlying	Strike price	Expiration date	Option type
2.49EUR	-	2.44 Bid Size: 750	2.59 Ask Size: 750	Progressive Corporat...	185.5082 USD	31/12/2078	Call

GlobeNewswire 07:00 Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix

GlobeNewswire 01:37 FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...

TeleTrader 09/06 EP updated results, EPP with 189 seats

TeleTrader 09/06 EPP's Weber claims party victory in EP election

GlobeNewswire 07/06 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 07/06 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...

GlobeNewswire 06/06 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...

GlobeNewswire 06/06 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...

GlobeNewswire 05/06 The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening

GlobeNewswire 05/06 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 05/06 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...

GlobeNewswire 04/06 Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...

GlobeNewswire 04/06 Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...

GlobeNewswire 03/06 Opthea To Present at Clinical Trials at the Summit Meeting

GlobeNewswire 03/06 TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire 03/06 MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...

GlobeNewswire 31/05 TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...

GlobeNewswire 30/05 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...

GlobeNewswire 30/05 4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...

GlobeNewswire 30/05 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...

GlobeNewswire 29/05 Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...

GlobeNewswire 28/05 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...

GlobeNewswire 28/05 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

GlobeNewswire 28/05 TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...

GlobeNewswire 25/05 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...

Morgan Stanley Knock-Out PGR/ DE000ME8Z0C0 /

If you wish to receive reply to your feedback, please provide your email address.